J4

• 临床研究 • Previous Articles     Next Articles

Application of serum PSA, fPSA detections andfPSA/PSA evaluation for diagnosis and therapy of prostatic diseases with DELFIA technique

WEI Li-qin1, SUN Wen-wei1, MA Qing-jie1*, LI Yang2   

  1. 1. Department of Nuclear Medicine, China-Japan Union Hospital , Jilin University,Changchun,130033,China;2. Department of Pathology, School of Basic Medical Sciences,Jilin University,Changchun 130021,China
  • Received:2005-07-30 Revised:1900-01-01 Online:2006-09-28 Published:2006-09-28
  • Contact: MA Qing-jie

Abstract: Objective To investigate the application of PSA, fPSA concentrations and fPSA/PSA value for diagnosis and therapy of prostatic diseases detected with dissociation enhanced lauthanide fluoroimmunoassay (DELFIA) technique. Methods Thirty-four cases of normal individuals were used as control group, 46 patients with prostatitis as prostatitis group, 123 patients with prostatic hyperplasia as BPH group and 39 patients with prostate cancer as prostate cancer group. PSA, fPSA concentrations and fPSA/PSA value were detected with DELFIA technique. Results In prostate cancer group, the PSA and fPSA concentrations were significantly higher than those in other 3 groups (P<0.01),as fPSA/PSA value was remarkably lower than those in the other 3 groups (P<0.05).However, the fPSA/PSA values in other 3 groups demonstrated no significant difference (P>0.05).Conclusion DELFI A technique is an effective method to improve the diagnosis and differential diagnosis of prostatic diseases, especially for prostate cancer.

Key words: prostatic neoplasms, PSA, fPSA, fPSA, PSA

CLC Number: 

  • R737.25